Palm Beach, FL 5/3/12 (StreetBeat) -- Mexican pharmaceutical products company Genomma Lab said on Thursday it will drop its offer for Prestige Brands Holdings (NYSE: PBH), after that company rejected the offer.
Genomma stock was up more 8.3 percent in early trading.
Prestige Brands said in March Genomma's proposal was "inadequate".
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.
StreetBeat Disclaimer
No comments:
Post a Comment